RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Optimal endobronchial tool sizes for targeting lung lesionswinr88 wrote
Hi Investclub
This makes the FDA application look good in my opinion. I copied the following statement from the Theralase Corporate presentation.
In June 2019, FDA confirmed in a Pre-Investigational New Drug (“IND”) conference call, that Theralase’sprotocol design for Study II was aligned with the industry guidelines (February,2018) for Bacillus Calmette Guerin (“BCG”)-Unresponsive NMIBC. In September 2019, Theralase submitted IND to FDA.
Hi winr88 thanks for digging that up. Right now all it is will be waiting for the 30 day official time frame to run its course. I feel like I'm at the horse races ... here comes Theralase by a 1/4 mile .... it's Theralase all the way ... and the winner is .... to be determined in 8 months